But the research topic is, for obvious reasons, controversial. Scientists have largely steered clear of trying to create full ...

Peak wind gusts in Boulder and possibly other locations along the Front Range don't pack the same punch they used to, ...

A Mesa biotech medical manufacturer is seeing an uptick in demand for its wound care products, leading to an expansion of its ...

A few tenants fill space at Hive Creative Office Campus, according to city staff reports. Anduril, a major defense contractor ...

Mesa Laboratories , Inc. (NASDAQ: MLAB), a $560 million market cap company based in Lakewood, Colorado, has announced a change in its independent registered public accounting firm. According to ...

It might look like the scope sitting by a window in the new building’s parasitology suite was situated to give its user a sweeping view of the county’s Overland Avenue operations campus in Kearny Mesa ...

Mesa Laboratories has a one year low of $83.68 and a one year high of $155.12. The stock has a market capitalization of $560.12 million, a PE ratio of -2.22 and a beta of 0.97.

Mesa Laboratories has a twelve month low of $83.68 and a twelve month high of $155.12. The stock has a market cap of $557.96 million, a PE ratio of -2.22 and a beta of 0.97.

Additionally, Mesa Laboratories announced a regular quarterly dividend of $0.16 per share, scheduled for payment on March 17, 2025, to shareholders on record as of February 28, 2025.

MESA LABORATORIES Hedge Fund Activity We have seen 68 institutional investors add shares of MESA LABORATORIES stock to their portfolio, and 75 decrease their positions in their most recent quarter.

Mesa Laboratories, Inc. reported strong financial performance for its third fiscal quarter ended December 31, 2024, with total revenues reaching $62.8 million, a 17.5% increase from the previous ...